Company: PHAT
Filing Date: 2025-05-06
Form Type: 3
Source: 0000950170-25-064587
Chunk: 1

Company: Phathom Pharmaceuticals, Inc.
Filing Date: 2025-05-06
Form: 3
Chunk 1
---
 Indirect Beneficial Ownership (Instr. 5) |     |     |                   |                       |     |     |   |
| Stock Option (Right to Buy)                |                                                   $15.21 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F1] - 01/18/2032 | Common Stock - 12,000 | N/A | N/A | D |
| Stock Option (Right to Buy)                |                                                    $8.35 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F2] - 01/18/2033 | Common Stock - 13,500 | N/A | N/A | D |
| Stock Option (Right to Buy)                |                                                    $7.60 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F3] - 01/17/2034 | Common Stock - 15,750 | N/A | N/A | D |
| Stock Option (Right to Buy)                |                                                    $5.76 | N/A                                                                         | N/A                                                    | N/A                                                      | N/A                                                   | N/A | N/A | [F4] - 01/18/2033 | Common Stock - 15,000 | N/A | N/A | D |

| ** Signature of Reporting Person 
 /s/ /s/ Robert Charles Breedlove | Date       
 05/06/2025 |

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. 
 Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.